Thymus and kidney transplant from baby donors for immune tolerance
Part of Immune system & allergy, Kidney & urinary clinical trials.
This study tests whether receiving a thymus and kidney from the same baby donor can help your body accept the new kidney without needing strong anti-rejection drugs. It is for people who need a kidney transplant and are willing to also receive a thymus from the same donor.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need to receive both a thymus and a kidney from the same donor.
- You must be between 18 and 65 years old.
- Your blood type and the donor's blood type must match.
- You must have a negative test for antibodies that attack the donor (DSA) and a negative crossmatch test.
- You must have had Epstein-Barr virus (EBV) in the past but not have an active infection.
- Your heart, liver, and blood cell counts need to be normal, and your weight should be between 40 and 100 kg.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a combined approach for kidney transplant patients: standard living-donor kidney transplant plus an added “stem cell” component taken from the same sibling donor. It aims to improve transplant outcomes by trying to better control the immune response and reduce complications.
This trial tests if a special stem cell treatment (using your own stem cells) can reset your immune system so you can accept a kidney from a deceased donor, even if you have very high antibody levels that make it hard to find a match. It's for people who have been waiting a long time and haven't had a transplant offer.
This trial tests a new approach to help teenagers and young adults keep their first kidney transplant working well. It looks at how to improve long-term success by carefully managing the immune system around the time of transplant.
This Phase 2 study tests a combined treatment—kidney transplant plus stem cell–based immune therapy—to help the body accept the new kidney with less immune attack. You may be able to take part if you have a matching sibling donor and meet key safety and health requirements.
This trial is testing a way to help your body accept a kidney transplant without needing lifelong anti-rejection drugs. It is for people getting a kidney from a living donor who is a relative and has a compatible blood type.
This study tries to use a stem cell transplant from your original kidney donor to help your body accept the kidney without needing lifelong anti-rejection drugs. You must have a perfectly matched sibling donor who is still available.
Hear when a new Kidney Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.